Fate Therapeutics, Inc. v. Shoreline Biosciences, Inc.

Good Law
United States District Court, Southern District of CaliforniaOctober 16, 20233:22-cv-00676California4,152 words

Opinion

Trial Court Opinion

UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF CALIFORNIA 10 FATE THERAPEUTICS, INC.; and Case No.: 22-cv-00676-H-MSB

WHITEHEAD INSTITUTE FOR

BIOMEDICAL RESEARCH, ORDER DENYING DEFENDANT’S

MOTION FOR ATTORNEY’S FEES Plaintiffs,

14 v. [Doc. No. 396.]

SHORELINE BIOSCIENCES, INC.,

Defendant. 17 On September 14, 2023, Defendant Shoreline Biosciences, Inc. (“Shoreline”) filed a motion for attorney’s fees. (Doc. No. 396.) On October 2, 2023, the Court took the matter under submission. (Doc. No. 409.) On October 2, 2023, Plaintiffs Fate Therapeutics, Inc. (“Fate”) and Whitehead Institute for Biomedical Research (“Whitehead”) filed a response in opposition to Shoreline’s motion. (Doc. No. 413.) On October 6, 2023, Shoreline filed a reply. (Doc. No. 423.) For the reasons below, the Court denies Shoreline’s motion for attorney’s fees. Background In this action, Plaintiffs asserted claims…

Sign in to read the full opinion

Create a free account to read the complete opinion text, citation history, and good-law status for this case.